Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsTo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE Highlights
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Creative Biolabs has developed a novel T cell-based cancer immunotherapy system intended to directly help our clients with their projects including biomarker selection, TCR generation, TCR design and construction, TCR gene packaging and delivery, TCR preclinical test. We are leveraging our TCR development platform for rapid and high-quality identification of TCRs candidates.
On the way of cancer immunological therapy, altering the specificity of T cell receptor is one of the popular strategies to genetically modify T cells to enhance the tumor-killing activity of T cells. The first step in TCR gene therapy is to isolate a high-affinity T-cell clone for a defined target antigen. However, the isolation of these rare tumor-reactive T cell clones is often the rate-limiting step in this procedure and these clones often have low affinity for the target antigen. The majority of identified tumor-associated antigens are also expressed at low levels in normal tissues and mechanisms of tolerance induction are likely to affect the quality of T cell responses to such antigens. Until now, several approaches have been used to generate TCRs that are specific for other antigens that are expressed by a wider variety of tumor cell types.
One of them is to use T cells from transgenic mice that express human MHC. By the use of this method, TCR transgenic model is developed by Creative Biolabs to determine the magnitude of T cell tolerance to tumor-associated antigen. T cells are incubated with tumor cells from the patient and TCR genes are cloned from T cells that react to the tumor cells so that high-affinity TCRs for the target antigen are generated.
Creative Biolabs has the capability to enable you to free up your time for core work and project. Our service can be designed to meet your special needs if you have any requirements. If you are interested in our service, please contact us by E-mail and our team will get back to you as soon as possible.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
